| Vivo Bio Tech Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 511509 |
NSE Symbol : - |
P/E(TTM) : 11.87 |
|
ISIN Demat : INE380K01017 |
Div & Yield% : 0.00 |
EPS(TTM) : 2.11 |
|
Book Value(₹) : 43.16 |
Market Cap(₹Cr) : 55.57 |
Face Value(₹) : 10.00 |
| Particulars | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 13.37 | 13.02 | 12.42 | 12.29 | 12.21 | 12.04 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 13.37 | 13.02 | 12.42 | 12.29 | 12.21 | 12.04 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.14 | 0.13 | 0.14 | 0.15 | 0.01 | 4.63 |
| Total Income | 13.50 | 13.15 | 12.56 | 12.44 | 12.22 | 16.67 |
| Total Expenditure | 7.86 | 7.60 | 6.89 | 7.15 | 6.60 | 6.36 |
| PBIDT | 5.64 | 5.55 | 5.66 | 5.29 | 5.62 | 10.30 |
| Interest | 1.40 | 1.47 | 1.50 | 1.68 | 1.84 | 2.06 |
| PBDT | 4.24 | 4.08 | 4.16 | 3.61 | 3.78 | 8.24 |
| Depreciation | 2.66 | 2.57 | 2.64 | 2.25 | 2.25 | 2.29 |
| Tax | 0.80 | 0.78 | 0.79 | 0.49 | 0.61 | 0.78 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.48 | -0.14 | -0.65 | -0.31 | 0.03 | -0.15 |
| Reported Profit After Tax | 1.26 | 0.87 | 1.37 | 1.19 | 0.89 | 5.31 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 1.26 | 0.87 | 1.37 | 1.19 | 0.89 | 5.31 |
| EPS (Unit Curr.) | 0.57 | 0.45 | 0.76 | 0.78 | 0.60 | 3.56 |
| EPS (Adj) (Unit Curr.) | 0.57 | 0.45 | 0.76 | 0.78 | 0.60 | 3.56 |
| Calculated EPS (Unit Curr.) | 0.57 | 0.39 | 0.69 | 0.69 | 0.55 | 3.56 |
| Calculated EPS (Adj) (Unit Curr.) | 0.57 | 0.39 | 0.69 | 0.69 | 0.55 | 3.56 |
| Calculated EPS (Ann.) (Unit Curr.) | 2.28 | 1.57 | 2.76 | 2.76 | 2.22 | 14.26 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 2.28 | 1.57 | 2.76 | 2.76 | 2.22 | 14.26 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 22.10 | 22.10 | 19.89 | 17.16 | 16.13 | 14.90 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 42.18 | 42.63 | 45.57 | 43.04 | 46.03 | 85.55 |
| PBDTM(%) | 31.71 | 31.34 | 33.49 | 29.37 | 30.96 | 68.44 |
| PATM(%) | 9.42 | 6.68 | 11.03 | 9.68 | 7.29 | 44.10 |
